Health Canada approves updated Novavax COVID-19 vaccine
Health Canada authorized Novavax’s updated COVID-19 vaccine that protects against currently circulating variants of the virus on Thursday.
The protein-based vaccine, called Nuvaxovid, targets the JN.1 subvariant of Omicron, replacing the previous version which targeted the XBB.1.5 Omicron subvariant, the agency said in an online update.
Health Canada recently asked provinces and territories to get rid of their older COVID-19 vaccines to ensure the most current vaccine will be used during this fall’s respiratory virus season.
Nuvaxovid is the second updated COVID-19 vaccine approved by Health Canada this week, following its authorization of Moderna’s updated mRNA vaccine on Tuesday.


